keyword
Keywords infection risk following biolo...

infection risk following biological therapy

https://read.qxmd.com/read/38280271/diagnosis-and-management-of-complications-following-pelvic-organ-prolapse-surgery-using-a-synthetic-mesh-french-national-guidelines-for-clinical-practice
#21
REVIEW
Xavier Deffieux, Marie-Aimée Perrouin-Verbe, Sandrine Campagne-Loiseau, Laurence Donon, Amélie Levesque, Jérome Rigaud, Nadja Stivalet, Aurélien Venara, Thibault Thubert, Adrien Vidart, Pierre-Olivier Bosset, Christine Revel-Delhom, Jean-Philippe Lucot, Jean François Hermieu
UNLABELLED: Complications associated with pelvic organ prolapse (POP) surgery using a synthetic non-absorbable mesh are uncommon (<5%) but may be severe and may hugely diminish the quality of life of some women. In drawing up these multidisciplinary clinical practice recommendations, the French National Authority for Health (Haute Autorité de santé, HAS) conducted an exhaustive review of the literature concerning the diagnosis, prevention, and management of complications associated with POP surgery using a synthetic mesh...
March 2024: European Journal of Obstetrics, Gynecology, and Reproductive Biology
https://read.qxmd.com/read/38262150/myocarditis-and-pericarditis-risk-with-mrna-covid-19-vaccination-compared-to-unvaccinated-individuals-a-retrospective-cohort-study-in-a-spanish-tertiary-hospital
#22
JOURNAL ARTICLE
Mikel Urroz Elizalde, Francisco Javier Guijarro Eguinoa, Arturo Gómez López de Las Huertas, María Jiménez-González, Elena Ramírez
OBJECTIVE: This study compared the incidence of pericarditis and myocarditis in patients exposed to mRNA COVID-19 vaccines to the incidence in those who were not vaccinated, considering the incidence of these conditions resulting from COVID-19 infection. METHODS: This was a retrospective cohort study of individuals assigned to health area of La Paz University Hospital in Spain. The exposure factor was vaccination with mRNA COVID-19 vaccines between December 27th, 2020 and January 9th, 2022 with a minimum follow-up of one month...
January 22, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38258675/effectiveness-of-a-fourth-dose-of-covid-19-mrna-vaccine-in-patients-with-systemic-autoimmune-rheumatic-diseases-using-disease-modifying-antirheumatic-drugs-an-emulated-target-trial
#23
JOURNAL ARTICLE
Jennifer S Hanberg, Xiaoqing Fu, Xiaosong Wang, Naomi J Patel, Yumeko Kawano, Abigail Schiff, Emily N Kowalski, Claire E Cook, Kathleen M M Vanni, Krishan Guzzo, Grace Qian, Katarina J Bade, Alene Saavedra, Rathnam Venkat, Shruthi Srivatsan, Yuqing Zhang, Jeffrey A Sparks, Zachary S Wallace
BACKGROUND: Patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs (DMARDs) might have blunted responses to COVID-19 vaccines. The initial mRNA vaccine series is defined as three doses for this population and a fourth booster dose is recommended. The effectiveness of the fourth dose in patients with systemic autoimmune rheumatic diseases using DMARDs is not well established. We aimed to assess the effectiveness of receiving versus not receiving a fourth dose of COVID-19 mRNA vaccine using a target trial framework, in a cohort of patients with systemic autoimmune rheumatic diseases receiving DMARD therapy...
January 2024: Lancet Rheumatology
https://read.qxmd.com/read/38251591/early-infection-risk-in-patients-with-systemic-lupus-erythematosus-treated-with-rituximab-or-belimumab-from-the-british-isles-lupus-assessment-group-biologics-register-bilag-br-a-prospective-longitudinal-study
#24
JOURNAL ARTICLE
Mia Rodziewicz, Sarah Dyball, Mark Lunt, Stephen McDonald, Emily Sutton, Ben Parker, Ian N Bruce
BACKGROUND: Patients with systemic lupus erythematosus (SLE) are at an increased risk of infection relative to the general population. We aimed to describe the frequency and risk factors for serious infections in patients with moderate-to-severe SLE treated with rituximab, belimumab, and standard of care therapies in a large national observational cohort. METHODS: The British Isles Lupus Assessment Group Biologics Register (BILAG-BR) is a UK-based prospective register of patients with SLE...
May 2023: Lancet Rheumatology
https://read.qxmd.com/read/38250882/no-waning-of-pneumococcal-vaccine-responses-over-time-in-people-with-inflammatory-arthritis-findings-from-a-single-centre-cohort
#25
JOURNAL ARTICLE
Deepak Nagra, Katie Bechman, Mark D Russell, Zijing Yang, Maryam Adas, Sujith Subesinghe, Andrew Rutherford, Edward Alveyn, Samir Patel, Chris Wincup, Arti Mahto, Christopher Baldwin, Ioasaf Karafotias, Andrew Cope, Sam Norton, James Galloway
Vaccination against pneumococcus reduces the risk of infective events, hospitalisation, and death in individual with inflammatory arthritis, particularly in those on immunomodulating therapy who are at risk of worse outcomes from pneumococcal disease. The objective of this study was to investigate the serological protection following vaccination against pneumococcal serovars over time. Methods: This was a single centre, retrospective cohort study of individuals with rheumatoid arthritis, psoriatic arthritis, or axial spondylarthritis who had previously received the PPSV23 polysaccharide pneumococcal vaccine (Pneumovax)...
January 10, 2024: Vaccines
https://read.qxmd.com/read/38244447/multiple-morbidities-are-associated-with-serious-infections-in-patients-with-rheumatoid-arthritis
#26
JOURNAL ARTICLE
Bradly A Kimbrough, Cynthia S Crowson, Ryan J Lennon, John M Davis, Anja Strangfeld, Elena Myasoedova
OBJECTIVE: To assess the association between a comprehensive list of morbidities and serious infection (SI) in patients with rheumatoid arthritis (RA). METHODS: This study evaluated SI risk associated with 55 comorbidities using a population-based inception cohort including all adult patients with incident RA from 1999 through 2014 with follow up through 2021. Morbidities and SI were ascertained using previously validated international classification of disease (ICD)-9 and ICD-10 codes...
January 15, 2024: Seminars in Arthritis and Rheumatism
https://read.qxmd.com/read/38234925/sars-cov-2-vaccination-and-the-multi-hit-hypothesis-of-oncogenesis
#27
REVIEW
Raquel Valdes Angues, Yolanda Perea Bustos
Cancer is a complex and dynamic disease. The "hallmarks of cancer" were proposed by Hanahan and Weinberg (2000) as a group of biological competencies that human cells attain as they progress from normalcy to neoplastic transformation. These competencies include self-sufficiency in proliferative signaling, insensitivity to growth-suppressive signals and immune surveillance, the ability to evade cell death, enabling replicative immortality, reprogramming energy metabolism, inducing angiogenesis, and activating tissue invasion and metastasis...
December 2023: Curēus
https://read.qxmd.com/read/38231300/red-light-emitting-diode-therapy-minimizes-the-functional-deleterious-effects-of-the-antiretroviral-ritonavir-on-osteoblasts-in-vitro
#28
JOURNAL ARTICLE
Matheus Menão Mochetti, Adriano Souza Pessoa, Cintia Kazuko Tokuhara, Mariana Liessa Rovis Sanches, Cassia Senger, Maria Aparecida Andrade Moreira, Rodrigo Cardoso Oliveira
PURPOSE: Long-term human immunodeficiency virus (HIV)-infected patients are considered at higher risk for osteoporosis. Among the various causes that lead these patients to lower bone health, there is the use of antiretroviral drugs (ARVs), especially protease inhibitors (PI), such as ritonavir (RTV). In this context, emerge the potential benefits of LED therapy, whose effects on bone cells are currently being extensively studied, showing a modulation in cell differentiation. However, it remains unclear if photobiostimulation might interfere with RTV effects on osteoblast differentiation...
January 17, 2024: Lasers in Medical Science
https://read.qxmd.com/read/38216022/impact-of-treatment-response-on-risk-of-serious-infections-in-patients-with-crohn-s-disease-secondary-analysis-of-the-pyramid-registry
#29
JOURNAL ARTICLE
Dhruv Ahuja, Jiyu Luo, Yuchen Qi, Gaurav Syal, Brigid S Boland, John Chang, Christopher Ma, Vipul Jairath, Ronghui Xu, Siddharth Singh
BACKGROUND AND AIMS: Traditional risk factors for serious infections with advanced therapies in patients with Crohn's disease (CD) have been assessed at baseline prior to starting therapy. We evaluated the impact of treatment response on the risk of serious infections in adalimumab-treated patients with CD through secondary analysis of the PYRAMID registry (NCT00524537). METHODS: We included patients with CD who initiated adalimumab and classified them as treatment responders (achieved steroid-free clinical remission based on patient-reported outcomes) vs...
January 10, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38206946/latent-and-active-tuberculosis-development-in-patients-with-rheumatoid-arthritis-receiving-biologic-disease-modifying-antirheumatic-drugs-a-single-center-prospective-study
#30
JOURNAL ARTICLE
Binh Bui Hai, Tuan Le Anh, Phuong Nguyen Thi Thu, Hung Nguyen Van, Giap Vu Van, Dung Hoang Van
Biologics have revolutionized the treatment of rheumatoid arthritis (RA) in recent years. However, data from clinical trials and actual clinical practice have shown that biologics currently in use may constitute a risk factor for reactivation of tuberculosis (TB) in patients with latent TB infection. Therefore, screening for latent and active TB infection is mandatory before initiating biologic therapy in patients with RA. This prospective study aimed to analyze the clinical characteristics of patients with RA receiving biologic disease-modifying antirheumatic drugs at Bach Mai Hospital, Vietnam, between 2017 and 2022, and to identify factors affecting the occurrence of active and latent TB infection among these patients...
2024: PloS One
https://read.qxmd.com/read/38196177/physician-made-pericardium-stent-graft-as-a-potential-endovascular-alternative-for-infectious-aortic-disease-an-ex-vivo-proof-of-concept-study
#31
JOURNAL ARTICLE
Benedikt Reutersberg, Lorenz Meuli, Alexander Zimmermann, Albert Busch
PURPOSE.: The treatment of infectious aortic disease is still challenging with open surgical debridement and reconstruction using biological, preferably autologous material, being the treatment of choice. However, these procedures are associated with high morbidity and mortality. Endovascular therapy is often considered a bridging method only, since the biologically inactive fabric of the covered stent grafts usually cannot be treated sufficiently with anti-infective agents in the event of a (obligate) consecutive secondary graft infection...
2024: Science Progress
https://read.qxmd.com/read/38188359/screening-with-urine-histoplasma-antigen-test-in-asymptomatic-patients-starting-tnf-alpha-inhibitor-therapy-a-cohort-study
#32
JOURNAL ARTICLE
Murillo M Cipolat, Débora R R Rodrigues, Letícia G Silveira, Inês G Silveira, Mahara S V Nothaft, Claiton V Brenol, Larissa R da Silva, Alessandro C Pasqualotto, Diego R Falci
BACKGROUND: Histoplasmosis is the second most frequent granulomatous disease in patients treated with tumor necrosis factor (TNF)-α inhibitors, second only to tuberculosis. However, there is limited information about pre-therapy screening procedures and the need for preventive treatments for patients who will start immunobiologicals. METHODS: This is a cohort study that evaluated the prevalence of histoplasmosis in asymptomatic HIV-negative patients before initiation of TNF-α inhibitors by testing for Histoplasma antigen in urine samples...
2024: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/38175471/european-practice-for-cdi-treatment
#33
JOURNAL ARTICLE
Fidelma Fitzpatrick, Robert Brennan, Joffrey van Prehn, Mairead Skally, Melissa Brady, Karen Burns, Christopher Rooney, Mark H Wilcox
Clostridioides difficile infection (CDI) remains a significant cause of morbidity and mortality worldwide. Historically, two antibiotics (metronidazole and vancomycin) and a recent third (fidaxomicin) have been used for CDI treatment; convincing data are now available showing that metronidazole is the least efficacious agent. The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) management guidance for CDI were updated in 2021. This guidance document outlines the treatment options for a variety of CDI clinical scenarios and for non-antimicrobial management (e...
2024: Advances in Experimental Medicine and Biology
https://read.qxmd.com/read/38163934/novel-strategies-for-preventing-dysbiosis-in-the-oral-cavity
#34
REVIEW
Mariana B Rebelo, Cláudia S Oliveira, Freni K Tavaria
Oral diseases affect over three billion people worldwide, making it one of the most common infections. Recent studies show that one approach to reducing the risk of chronic infections, such as caries, gingivitis, periodontitis, and halitosis, is to control the ecology of the oral microbiome instead of completely removing both the harmful and beneficial microorganisms. This is based on the knowledge that oral diseases are not caused by a single pathogen but rather by a shift in the homeostasis of the entire microbiota, a process known as dysbiosis...
October 16, 2023: Frontiers in Bioscience (Elite Edition)
https://read.qxmd.com/read/38137842/a-rare-case-of-pulmonary-embolism-deep-vein-thrombosis-bilateral-avascular-necrosis-of-the-femoral-head-and-miscarriage-following-covid-19-in-a-patient-with-multiple-genetic-coagulation-factor-deficiency-a-case-report
#35
Nevena Georgieva Ivanova
The coronavirus disease (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The most common symptoms of COVID-19 are respiratory symptoms, but some patients develop severe thrombotic complications. Studies have looked into the association between the disease severity in COVID-19 patients and polymorphisms in the genes encoding prothrombotic and cardiovascular risk factors. The presented rare case describes inflammatory and acute thrombotic complications with musculoskeletal involvement in a patient with combined coagulation genetic defects...
November 22, 2023: Life
https://read.qxmd.com/read/38135860/torari-tofacitinib-in-rheumatoid-arthritis-a-real-life-experience-in-italy-effectiveness-safety-profile-of-tofacitinib-and-concordance-between-patient-reported-outcomes-and-physician-s-global-assessment-of-disease-activity-in-a-retrospective-study-in-central
#36
MULTICENTER STUDY
Francesco D'Alessandro, Massimiliano Cazzato, Elenia Laurino, Riccardo Morganti, Marco Bardelli, Bruno Frediani, Claudia Buongarzone, Gianluca Moroncini, Serena Guiducci, Laura Cometi, Maurizio Benucci, Francesca Ligobbi, Daniela Marotto, Marta Mosca
INTRODUCTION: The use of Janus Kinase Inhibitors (JAK-Is) in rheumatoid arthritis (RA) has entered in daily practice. In consideration of ORAL-Surveillance trial and the new EULAR recommendations, real-world data are needed to assess Jak-Is safety and effectiveness. The multicenter study presented here aimed to evaluate effectiveness and safety of tofacitinib in a real-life cohort. METHODS: A retrospective analysis was performed from September 2021 to December 2022...
February 2024: Clinical Rheumatology
https://read.qxmd.com/read/38125053/risk-of-tuberculosis-in-children-with-rheumatologic-diseases-treated-with-biological-agents-a-cross-sectional-cohort-study
#37
JOURNAL ARTICLE
Nuri Bayram, Özge Altuğ Gücenmez, Balahan Makay, Elif Kıymet, Elif Böncüoğlu, Şahika Şahinkaya, Yelda Sorguç, Aybüke Akaslan Kara, Kamile Ötiken Arıkan, İlker Devrim
OBJECTIVES: This study aimed to evaluate the risk of tuberculosis (TB) disease in children receiving biological agents for rheumatologic diseases, focusing on appropriate screening tests in a high-priority country for TB control. PATIENTS AND METHODS: One hundred nine children (56 females, 53 males; range, 3.4 to 16.2 years) who received any biological agent for rheumatologic diseases for more than two years between May 2012 and October 2021 were included in this retrospective study...
December 2023: Archives of Rheumatology
https://read.qxmd.com/read/38101075/development-of-a-highly-cytotoxic-clinical-grade-virus-specific-t-cell-product-for-adoptive-t-cell-therapy
#38
JOURNAL ARTICLE
Fernanda Agostini Rocha, Caio Raony Farina Silveira, Ancély Ferreira Dos Santos, Ana Carolina Buzzo Stefanini, Nelson Hamerschlak, Luciana Cavalheiro Marti
At present, recipients of allogeneic hematopoietic stem-cells are still suffering from recurrent infections after transplantation. Infusion of virus-specific T cells (VST) post-transplant reportedly fights several viruses without increasing the risk of de novo graft-versus-host disease. This study targeted cytomegalovirus (CMV) for the development of an innovative approach for generating a very specific VST product following Good Manufacturing Practices (GMP) guidelines. We used a sterile disposable compartment named the Leukoreduction System Chamber (LRS-chamber) from the apheresis platelet donation kit as the starting material, which has demonstrated high levels of T cells...
December 10, 2023: Cellular Immunology
https://read.qxmd.com/read/38095034/-iatrogenic-colitis-following-immunotherapy-monocentric-retrospective-study-at-the-university-hospital-of-li%C3%A3-ge
#39
JOURNAL ARTICLE
Fernand Weerts, Catherine Loly, Edouard Louis
Checkpoint inhibitor colitis is a complication that is often underestimated when it is slow-grade, and results in relatively few hospital admissions compared to its frequency of occurrence. A strict history-taking approach, combined with an endoscopic work-up in cases of severity, is recommended. The use of the fecal calprotectin may also be useful. When used appropriately, the various lines of treatment are generally effective, and second-line therapies (biotherapies) are rarely used. However, recent evidence suggests that patients with severe symptoms should be treated more rapidly with biological therapies, especially if severity is endoscopically confirmed, as corticosteroids carry a greater risk of infection...
December 2023: Revue Médicale de Liège
https://read.qxmd.com/read/38069049/neuroprotection-and-beyond-the-central-role-of-cb1-and-cb2-receptors-in-stroke-recovery
#40
REVIEW
Bashir Bietar, Sophie Tanner, Christian Lehmann
The endocannabinoid system, with its intricate presence in numerous cells, tissues, and organs, offers a compelling avenue for therapeutic interventions. Central to this system are the cannabinoid receptors 1 and 2 (CB1R and CB2R), whose ubiquity can introduce complexities in targeted treatments due to their wide-ranging physiological influence. Injuries to the central nervous system (CNS), including strokes and traumatic brain injuries, induce localized pro-inflammatory immune responses, termed neuroinflammation...
November 24, 2023: International Journal of Molecular Sciences
keyword
keyword
104481
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.